Astal Laboratories Stock Screener | Share Price & Fundamental Analysis
ASTALLTD
Trading & Distributors
Screen Astal Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹81.66
▲
2.15 (2.70%)
Market Cap
₹93.66 Cr.
P/E Ratio (TTM)
8.64
P/B Ratio
1.96
EPS (TTM)
₹9.08
Dividend Yield
-
Debt to Equity
0.23
52W High
₹100.62
52W Low
₹68.49
Operating Margin
16.00%
Profit Margin
9.90%
Revenue (TTM)
₹101.00
EBITDA
₹15.00
Net Income
₹10.00
Total Assets
₹63.00
Total Equity
₹36.00
Astal Laboratories Share Price History - Stock Screener Chart
Screen ASTALLTD historical share price movements with interactive charts. Analyze price trends and patterns.
Astal Laboratories Company Profile - Fundamental Screener
Screen Astal Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ASTALLTD shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE307N01014
Astal Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ASTALLTD balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 63 | 37 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Current Assets | 46 | 27 | 6 | 0 | 0 | 5 | 5 | 5 | 5 | 5 |
| Fixed Assets | 11 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 63 | 37 | 10 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Current Liabilities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 36 | 23 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Share Capital | 10 | 10 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 22 | 14 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Screen ASTALLTD income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 101 | 64 | 24 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 86 | 52 | 23 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 15 | 13 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 16.00% | 20.00% | 5.00% | -4.00% | 0.00% | 12.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 13 | 12 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 10 | 9 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | 9.90 | 9.08 | 1.55 | 0.04 | -0.04 | 0.02 | -0.07 | -0.21 | -0.02 | 0.01 | 0.02 | 0.46 |
Astal Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ASTALLTD cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -13 | -6 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | -8 | -6 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 3 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -17 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen ASTALLTD shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Aug | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 19.93% | 19.93% | 18.19% | 18.19% | 19.93% | 19.93% | 19.93% | 19.93% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 73.80% | 73.42% | 73.61% | 73.50% | 73.53% | 73.53% | 73.49% | 73.42% |
| Other Holding | 6.26% | 6.65% | 8.20% | 8.31% | 6.53% | 6.54% | 6.58% | 6.65% |
| Shareholder Count | 2,302 | 2,721 | 2,950 | 2,899 | 1,252 | 1,241 | 1,242 | 1,629 |
Astal Laboratories Dividend Screener - Share Yield Analysis
Screen ASTALLTD dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Astal Laboratories Index Membership - Market Screener Classification
Screen ASTALLTD by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Astal Laboratories Market Events Screener - Corporate Actions
Screen ASTALLTD market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -13.90% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.18% |
| 2025-11-06 | 2025-11-06 | Extraordinary General Meeting | NA | -1.89% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 6.22% |
| 2025-05-19 | 2025-05-19 | Quarterly Result Announcement | NA | 8.40% |
| 2025-01-27 | 2025-01-27 | Quarterly Result Announcement | NA | 14.76% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -3.14% |
| 2024-08-05 | 2024-08-05 | Annual General Meeting | NA | 36.71% |
| 2023-12-19 | 2023-12-19 | Change Of Name | NA | 0.00% |
Astal Laboratories Competitors Screener - Peer Comparison
Screen ASTALLTD competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,366 | 11.53 | 99,562 | 11.11% | 1,821 | 46.19 |
| Elitecon International | 14,609 | 62.00 | 551 | 55040.00% | 70 | 38.77 |
| MMTC | 9,465 | 44.87 | 263 | 28.63% | 87 | 50.67 |
| BN Agrochem | 3,655 | 54.14 | 367 | 5071.83% | 20 | 47.86 |
| MSTC | 3,401 | 8.36 | 388 | -25.38% | 407 | 42.74 |
| Ravindra Energy | 2,514 | 37.03 | 262 | 79.10% | 23 | 32.66 |
| Vintage Coffee & Beverages | 2,385 | 41.50 | 313 | 136.92% | 40 | 54.00 |
| TCC Concept | 2,115 | 44.85 | 90 | 14.72% | 42 | 42.00 |
| Creative Newtech | 1,067 | 17.98 | 1,802 | 3.48% | 53 | 44.54 |
| Polo Queen Industrial And Fintech | 1,025 | 383.63 | 81 | 15.16% | 3 | 36.11 |
Astal Laboratories Company Announcements - News Screener
Screen ASTALLTD latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Announcement Under Regulation 30 (LODR)- In-Principle Approval | View |
| 2026-01-03 | Closure of Trading Window | View |
| 2025-12-29 | Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Signing Of Letter Of Intent. | View |
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-24 | Intimation Of REACH Compliance Certificate. | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Results- Financial Results For September 30 2025 | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 14Th November 2025 | View |
| 2025-11-10 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 14Th November 2025 | View |
| 2025-11-09 | Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | View |
| 2025-11-07 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-06 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-05 | Shareholders Meeting- EGM - Intimation Of The Corrigendum To The EGM Notice | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-13 | Shareholders Meeting- Notice Of Extra Ordinary General Meeting. | View |
| 2025-10-10 | Shareholders Meeting- EGM 06-11-2025 | View |
| 2025-10-10 | Announcement under Regulation 30 (LODR)-Preferential Issue | View |